Johnston, S., O’Shaughnessy, J., Martin, M., Huober, J., Toi, M., Sohn, J., . . . Goetz, M. P. (2021). Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups. Nature Portfolio.
Chicago Style (17th ed.) CitationJohnston, Stephen, et al. Abemaciclib as Initial Therapy for Advanced Breast Cancer: MONARCH 3 Updated Results in Prognostic Subgroups. Nature Portfolio, 2021.
MLA (8th ed.) CitationJohnston, Stephen, et al. Abemaciclib as Initial Therapy for Advanced Breast Cancer: MONARCH 3 Updated Results in Prognostic Subgroups. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.